Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Egetis Therapeutics | EGTX | Sep 20, 2024 | 4.59 | -3.16 |
Elicera Therapeutics | ELIC | Sep 20, 2024 | 1.70 | -0.59 |
Ellen | ELN | Sep 20, 2024 | 1.03 | +4.57 |
Enorama Pharma | ERMA | Sep 20, 2024 | 4.93 | -5.19 |
Enzymatica | ENZY | Sep 20, 2024 | 2.38 | 0.00 |
EQL Pharma | EQL | Sep 20, 2024 | 54.80 | +1.86 |
ExpreS2ion Biotech Holding | EXPRS2 | Sep 20, 2024 | 0.98 | -6.84 |
Flerie AB | FLERIE | Sep 20, 2024 | 42.75 | +0.25 |
Fluicell | FLUI | Sep 20, 2024 | 0.08 | -2.50 |
Gabather | GABA | Sep 20, 2024 | 0.57 | -2.07 |
Genovis | GENO | Sep 20, 2024 | 22.50 | -2.17 |
Glycorex Transplantati.. | GTABB | Sep 20, 2024 | 1.69 | -0.30 |
Guard Therapeutics International | GUARD | Sep 20, 2024 | 29.00 | +0.69 |
Hamlet BioPharma AB (publ) | HAMLETB | Sep 20, 2024 | 3.57 | +3.78 |
Hansa Biopharma | HNSA | Sep 20, 2024 | 41.06 | -3.71 |
Hemply Balance | HMPLY | Sep 20, 2024 | 0.03 | -9.68 |
I-tech | ITECH | Sep 20, 2024 | 50.00 | 0.00 |
Immunovia | IMMNOV | Sep 20, 2024 | 0.92 | -3.58 |
Infant Bacterial Therapeutics B | IBTB | Sep 20, 2024 | 34.90 | +0.58 |
Initiator Pharma | INIT | Sep 20, 2024 | 7.30 | -0.68 |
Intervacc | IVACC | Sep 20, 2024 | 3.64 | -0.55 |
IRLAB Therapeutics A | IRLABA | Sep 20, 2024 | 12.85 | +1.98 |
Isofol Medical | ISOFOL | Sep 20, 2024 | 2.61 | -2.25 |
Kancera | KAN | Sep 20, 2024 | 1.93 | -6.54 |
Klaria Pharma Holding | KLAR | Sep 20, 2024 | 0.73 | +1.95 |
LIDDS | LIDDS | Sep 20, 2024 | 0.14 | +6.11 |
Lipidor | LIPI | Sep 20, 2024 | 0.14 | +7.00 |
Lipigon Pharmaceuticals | LPGO | Sep 20, 2024 | 0.26 | -3.89 |
Lipum | LIPUM | Sep 20, 2024 | 13.00 | +7.44 |
Lumito | LUMITO | Sep 20, 2024 | 0.79 | -1.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.